Julian Adams
2012
In 2012, Julian Adams earned a total compensation of $1.2M as President of R&D at Infinity Pharmaceuticals, a 21% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $191,416 |
|---|---|
| Option Awards | $592,390 |
| Salary | $452,200 |
| Other | $1,806 |
| Total | $1,237,812 |
Adams received $592.4K in option awards, accounting for 48% of the total pay in 2012.
Adams also received $191.4K in non-equity incentive plan, $452.2K in salary and $1.8K in other compensation.
Rankings
In 2012, Julian Adams' compensation ranked 5,299th out of 11,487 executives tracked by ExecPay. In other words, Adams earned more than 53.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,299 out of 11,487 | 54th |
Division Manufacturing | 1,861 out of 4,253 | 56th |
Major group Chemicals And Allied Products | 448 out of 1,198 | 63rd |
Industry group Drugs | 295 out of 920 | 68th |
Industry Pharmaceutical Preparations | 230 out of 700 | 67th |
Source: SEC filing on April 27, 2015.
Adams' colleagues
We found three more compensation records of executives who worked with Julian Adams at Infinity Pharmaceuticals in 2012.